ADVENTRX Pharmaceuticals Inc (Anx) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVENTRX Pharmaceuticals Inc (Anx)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: georgiabiotech who wrote (200)	7/8/2007 6:27:28 PM
From: Keith Feral	Read Replies (1) of 418

Sure, read the headlines. It's a pure isomer of leucovorin for osteogenic sarcoma. Leucovorin is the most widely prescribed drug in cancer, so why not find additional applications for this isomer. It's not going to compete with Cofactor for colorectal cancer or any other application in any way shape or form, except for the NDA filed for this form of bone cancer in children. Naturally, I think a direct form of folate would be much better for this kind of bone treatment, since Cofactor works so well on bone marrow complications.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next